Century Therapeutics Inc (IPSC) Actualités

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

PHILADELPHIA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

– Expansion of Phase 1 CALiPSO-1 trial of CNTY-101 in autoimmune disease to include diffuse cutaneous systemic...

Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting

– Company to share preclinical data across diverse pipeline of iNK, γδ iT, and αβ iT cell therapy programs for...

Form 144 - Report of proposed sale of securities

Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference

PHILADELPHIA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities